SANTA CLARA, Calif. and PUNE, India , May 7, 2026
Persistent Systems announced it has achieved the Databricks Brickbuilder Specialization for Healthcare and Life Sciences (HLS), strengthening its position as a major provider of AI-driven healthcare data modernization and regulated enterprise solutions. The recognition validates Persistent’s ability to deliver production-ready, governed data and artificial intelligence platforms for pharmaceutical, biotechnology, medical device and healthcare organizations operating in highly regulated environments.
The achievement comes as healthcare and life sciences organizations face increasing pressure to accelerate clinical development, drug discovery, patient data analysis and real-world evidence generation while managing growing volumes of complex multimodal data. Industry leaders are rapidly investing in scalable AI infrastructure capable of integrating clinical records, genomics, imaging and operational data to improve decision-making and patient outcomes. Persistent’s expanded collaboration with Databricks is expected to support these evolving demands through enterprise-scale AI deployment and advanced data governance capabilities.
Persistent Targets AI Transformation in Regulated Healthcare
Persistent stated that the specialization recognizes its expertise in deploying the Databricks Data Intelligence Platform to help organizations unify fragmented healthcare datasets into a centralized and AI-ready environment. The platform enables healthcare providers, payers, pharmaceutical companies, biotechnology firms and medical device manufacturers to accelerate clinical workflows while maintaining compliance and governance standards required in regulated sectors.
The company highlighted that traditional healthcare IT infrastructures often struggle to integrate highly diverse data sources such as genomic sequencing information, clinical trial records, patient histories, diagnostic imaging and operational healthcare data. By leveraging Databricks technologies including Delta Lake, Unity Catalog and Mosaic AI, Persistent aims to help organizations streamline secure data management, improve interoperability and operationalize trusted AI models across enterprise environments.
Advertisement
According to Persistent executives, the company’s AI-enabled solutions are designed to support use cases including clinical trial optimization, biomarker discovery, patient risk prediction, pharmacovigilance and real-world evidence generation. The organization emphasized that the growing importance of AI in healthcare requires scalable, governed and compliant infrastructure capable of supporting enterprise adoption beyond isolated pilot projects.
Ganesh Nathella, Executive Vice President and General Manager of Persistent’s Healthcare and Life Sciences Business, said the industry focus is shifting from simply collecting healthcare data to making that data actionable across clinical, operational and research environments. He noted that the company’s collaboration with Databricks is helping healthcare organizations build more connected and insight-driven ecosystems that can accelerate innovation and improve patient outcomes.
Databricks Collaboration Expands Real-World Clinical AI Use Cases
Persistent and Databricks continue expanding joint go-to-market initiatives aimed at delivering measurable outcomes for healthcare and life sciences customers. The companies reported that Persistent has already supported organizations including a Contract Research Organization (CRO) seeking to improve trial success rates and a scientific instruments and medical devices company focused on accelerating innovation through scalable AI deployment.
Persistent currently serves as a Databricks Global Systems Integrator partner at the Silver Tier level and has accumulated more than 900 Databricks certifications, reinforcing its growing specialization in cloud-based data engineering and AI transformation services. The partnership reflects broader healthcare industry trends toward adoption of AI-powered analytics platforms capable of handling increasingly complex clinical and operational datasets.
Databricks executives noted that Persistent’s specialization demonstrates its ability to transform healthcare and life sciences data into practical clinical and operational insights. The collaboration is expected to support healthcare organizations pursuing faster drug discovery, optimized clinical development strategies and improved patient care models through advanced analytics and machine learning technologies.
Healthcare AI Demand Continues Accelerating Globally
Industry analysts continue identifying healthcare and life sciences as one of the fastest-growing sectors for enterprise AI adoption, particularly as organizations seek to reduce clinical trial timelines, improve regulatory compliance and accelerate precision medicine initiatives. Persistent’s latest recognition positions the company to capture growing demand for scalable healthcare AI platforms capable of supporting highly regulated workflows across pharmaceutical, biotech and medical device industries.
Headquartered in India and operating across 18 countries, Persistent continues expanding its global footprint in digital engineering, cloud modernization, healthcare AI and enterprise automation. The company’s healthcare-focused AI initiatives align with broader industry efforts to modernize healthcare infrastructure through secure and governed data ecosystems capable of supporting next-generation innovation.
Source: Persistent Systems press release
